You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 27, 2026

HISTAMINE PHOSPHATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Histamine Phosphate, and when can generic versions of Histamine Phosphate launch?

Histamine Phosphate is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in HISTAMINE PHOSPHATE is histamine phosphate. There is one drug master file entry for this compound. Additional details are available on the histamine phosphate profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for HISTAMINE PHOSPHATE?
  • What are the global sales for HISTAMINE PHOSPHATE?
  • What is Average Wholesale Price for HISTAMINE PHOSPHATE?
Summary for HISTAMINE PHOSPHATE
Drug patent expirations by year for HISTAMINE PHOSPHATE
Recent Clinical Trials for HISTAMINE PHOSPHATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Kuopio University HospitalN/A

See all HISTAMINE PHOSPHATE clinical trials

Medical Subject Heading (MeSH) Categories for HISTAMINE PHOSPHATE
Anatomical Therapeutic Chemical (ATC) Classes for HISTAMINE PHOSPHATE

US Patents and Regulatory Information for HISTAMINE PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly HISTAMINE PHOSPHATE histamine phosphate INJECTABLE;INJECTION 000734-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Lilly HISTAMINE PHOSPHATE histamine phosphate INJECTABLE;INJECTION 000734-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Lilly HISTAMINE PHOSPHATE histamine phosphate INJECTABLE;INJECTION 000734-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Histamine Phosphate

Last updated: February 20, 2026

Histamine phosphate is primarily used as a diagnostic reagent in allergy testing and for research purposes. While it does not have a significant direct therapeutic application, its market landscape is influenced by allied sectors such as diagnostics, immunology, and pharmaceuticals.

Market Overview

Histamine phosphate is a chemical compound used in skin allergy tests to provoke a localized allergic response. The demand hinges on diagnostic procedures in allergology, as well as research activities in immunology.

The global diagnostic allergy testing market was valued at approximately USD 2.9 billion in 2022 and projected to grow at a compound annual growth rate (CAGR) of 9.2% through 2030 [1]. Histamine phosphate contributes as a reagent within this sector, but its precise market size remains a sub-segment.

Key Market Drivers

  • Increased prevalence of allergic conditions: The World Allergy Organization reports that up to 30% of the global population suffers from allergic rhinitis, driving test demand.
  • Expanding allergy diagnostics: The rise in outpatient testing increases consumption of histamine phosphate, especially with the adoption of standardized skin testing protocols.
  • Research and development in immunology: Growth in biomedical research utilizing histamine as a biological marker sustains demand in laboratory settings.

Market Limitations

  • Regulatory restrictions: The use of histamine phosphate as a diagnostic reagent must meet strict safety standards, limiting rapid expansion.
  • Competitive landscape: Synthetic alternatives and advanced immunoassays reduce reliance on traditional histamine skin testing.

Production and Supply Chain

Major raw material sources include histidine, which is chemically processed to produce histamine phosphate. Synthesis purity standards influence production costs, with certifications required for pharmaceutical-grade reagents.

Leading manufacturers include laboratories and biotech companies such as Sigma-Aldrich and Thermo Fisher Scientific, which supply histamine phosphate in bulk for diagnostic and research use.

Financial Trajectory

Revenue Streams

  • Diagnostic reagents segment: Estimated to account for 65% of sales within allergy testing supplies.
  • Research reagents segment: Approximately 35%, primarily used by biotech and pharmaceutical companies.

Market Growth Forecast

Between 2023 and 2028, the global market for histamine phosphate as a reagent is expected to grow modestly, around 4-6% annually, reflecting broader trends in diagnostics and laboratory research.

Pricing Trends

Unit prices range from USD 20 to USD 60 per gram, depending on purity grade and supplier. Bulk procurement and academic discounts influence overall margins.

Investment and R&D

Limited innovation is evident given the reagent's established role; however, incremental R&D focuses on enhancing stability and reducing allergenic variability.

Competitive Landscape

Company Market Share Product Focus Geographic Coverage
Sigma-Aldrich 35% Diagnostic and research-grade histamine phosphate Global
Thermo Fisher Scientific 25% Laboratory reagents Global
Others 40% Regional suppliers, generics Regional

The concentration suggests a moderately fragmented market but with clear dominant players.

Regulatory Environment

Compliance with Good Manufacturing Practice (GMP), ISO standards, and local drug and diagnostic regulations influences market accessibility. Future certifications or approvals could unlock new markets.

Strategic Outlook

Market stability hinges on the sustained need for allergy diagnostics amid rising allergy prevalence. Innovation in allergy testing methodologies could alter demand dynamics.

Key Takeaways

  • The histamine phosphate market is a subset of the broader diagnostics and immunology sectors.
  • Growth is linked primarily to increased allergy diagnosis and research activities.
  • Major players dominate supply, with incremental growth forecasted through 2028.
  • Regulatory, scientific, and supply chain factors shape market dynamics.
  • High expertise requirements and stable demand position the commodity as a steady, incremental growth segment.

FAQs

1. What primary uses does histamine phosphate have in medicine?
Histamine phosphate is used mainly as a reagent in skin allergy testing and research.

2. How does the growth of allergy diagnostics impact the histamine phosphate market?
Rising allergy diagnoses increase demand for skin testing reagents, including histamine phosphate.

3. What factors restrict market expansion?
Regulatory restrictions, competition from advanced diagnostics, and the stable nature of existing testing protocols limit expansion.

4. Who are the key suppliers of histamine phosphate?
Sigma-Aldrich and Thermo Fisher Scientific are the leading global suppliers.

5. Is there active innovation in histamine phosphate production?
Limited innovation exists; focus is on improving reagent stability and purity standards.


References

[1] MarketsandMarkets. (2022). "Global Allergy Diagnostics Market."

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.